Literature DB >> 19585060

Use of tacrolimus ointment in vitiligo alone or in combination therapy.

S Berti1, G Buggiani, T Lotti.   

Abstract

Current treatments for vitiligo are largely unsatisfactory. Topical corticosteroids and phototherapy (narrow-band UVB and psoralen+UVA) are the most prescribed, however, these therapies are often not effective and have important side-effect, especially when used for a long time. Many studies have reported the efficacy and safety of tacrolimus ointment in adults and children with vitiligo, particularly when located on the head and neck. Successful treatment is possible when it is combined with other therapies, such as narrow-band UVB, microphototherapy, helium-neon laser, or narrow-band excimer laser.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585060

Source DB:  PubMed          Journal:  Skin Therapy Lett        ISSN: 1201-5989


  4 in total

1.  Epidermal permeability barrier recovery is delayed in vitiligo-involved sites.

Authors:  J Liu; W Y Man; C Z Lv; S P Song; Y J Shi; P M Elias; M Q Man
Journal:  Skin Pharmacol Physiol       Date:  2010-02-25       Impact factor: 3.479

Review 2.  Current Management of Pediatric Vitiligo.

Authors:  Freya Van Driessche; Nanette Silverberg
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

3.  The effects of tacrolimus plus phototherapy in the treatment of vitiligo: a meta-analysis.

Authors:  Yujie Dong; Qi Yang; Baofeng Guo; Jiajing Zhu; Xiaojie Sun
Journal:  Arch Dermatol Res       Date:  2020-08-12       Impact factor: 3.017

4.  Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo.

Authors:  Luyan Tang; Jian Li; Wenwen Fu; Wenyu Wu; Jinhua Xu
Journal:  Aging (Albany NY)       Date:  2019-12-21       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.